PHIO - Phio Pharmaceuticals GAAP EPS of -$0.26 November, 10 2022 05:28 PM Phio Pharmaceuticals Corp. Phio Pharmaceuticals press release ( NASDAQ: PHIO ): Q3 GAAP EPS of -$0.26. At September 30, 2022, the Company had cash of $14.5 million as compared with $24.1 million at December 31, 2021. For further details see: Phio Pharmaceuticals GAAP EPS of -$0.26